循環線維芽細胞:組織線維症の細胞性メディエーター
Xinya Guo1, Jianyu Lu1, Yiyao Du1
1Department of Burn Surgery, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
International journal of molecular sciences
|January 28, 2026
まとめ
主要な健康脅威である線維症は、過剰な組織修復を伴う。新しい研究は、線維症の主要な原因として循環線維芽細胞を強調しており、新しい治療標的の可能性を提供している。
科学分野:
- 病理学
- 免疫学
- 再生医療
背景:
- 線維症は、複数の臓器に影響を与える有害な過剰な組織修復反応であり、世界的な健康問題となっている。
- 線維症メカニズムとエフェクター細胞の複雑さのため、現在の線維症防止治療は効果が限定的である。
- オミクスと機械学習の進歩は、線維症における細胞の役割の理解を深めている。
研究 の 目的:
- 線維症における循環線維芽細胞の特性と役割をレビューする。
- 線維芽細胞の募集と分化のメカニズムを探る。
- 線維症防止戦略のための潜在的な治療標的として線維芽細胞を特定する。
主な方法:
- 線維症と線維芽細胞に関する最近の研究の文献レビュー。
- ハイスループットオミクスデータと機械学習アプリケーションの分析。
- 線維芽細胞の生物学と病理学に関する情報の合成。
主要な成果:
- 循環線維芽細胞は骨髄由来で、損傷部位に募集される。
- 線維芽細胞は、様々な実質および非実質組織の線維症に寄与する。
- これらの細胞は、炎症、組織修復、線維症の進行において役割を果たす。
結論:
- 循環線維芽細胞は、多様な組織にわたる線維症の重要な原因である。
- 線維症の研究には、線維芽細胞の募集と分化の理解が不可欠である。
- 線維芽細胞は、新しい線維症防止治療薬の開発のための有望な標的を表す。
関連する概念動画
Coronary Circulation
7.1K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.1K
Cystic Fibrosis: Pathogenesis
868
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
868
Fetal Circulation
2.8K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
2.8K
Overview of Pulmonary Circulation
3.0K
The pulmonary circulation is a vital system in our body that acts as a bridge between the respiratory and cardiovascular systems. It serves as a transport network for deoxygenated blood from the heart to the lungs and then returns oxygen-rich blood back to the heart.
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
The process begins with the right ventricle of the heart pumping deoxygenated blood into the pulmonary trunk. This large vessel extends about 5 centimeters before splitting into the left and right pulmonary arteries. These arteries...
3.0K
Cystic Fibrosis: Management
520
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
520
Receptor-mediated Endocytosis
110.8K
Overview
110.8K


